Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

The scalp's microorganisms significantly affect hair health and disease.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Moth-eaten alopecia is linked to various skin diseases and requires early treatment to prevent worsening.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Hair and nails are similar keratin structures with different shapes and growth, affected by the same diseases and environmental factors.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.